Revolutionizing Healthcare: using machine learning to power clinical trials

25 May, 2022, saw the seventeenth virtual Revolutionizing Healthcare engagement sessions of the van der Schaar Lab and its audience of practising clinicians.

This was the first of a double-header on clinical trials. The second session will take place on 7 July.

At the beginning of the session, Mihaela and our panellists offered short introductory presentations framing the problems clinicians are currently facing in regards to clinical trials, defining important terms, and giving examples of current challenges and opportunities.

The latter part of the session featured an engaging clinician roundtable comprising an expert panel of four specialists in the area of clinical trials:

Prof Carsten Utoft Niemann, MD (Associate Professor and Head of the Chronic Lymphocytic Leukemia (CLL) Laboratory and Clinical Research Program for CLL at Rigshospitalet’s Department of Hematology, Copenhagen)
Dr Eoin McKinney, MD  (University lecturer in renal medicine, University of Cambridge; Honorary consultant in nephrology and transplantation, Cambridge University Hospitals NHS Foundation Trust)
Dr Pierre Marquet, MD (Head of the ‘Pharmacology, Toxicology and Pharmacovigilance’ Department at the University Hospital of Limoges; Director of the U1248 research unit ‘Pharmacology & Transplantation’ at the French Institute of Medical and Health Research; President of the European Association of Clinical Pharmacology and Therapeutics) 
Prof Richard Peck, MD (Honorary Professor in Pharmacology and Therapeutics at the University of Liverpool; Former Global Head of Clinical Pharmacology at Roche)

Our panelists answered a number of questions posed by Mihaela and the audience. 

If you didn’t manage to join us last week, we’d strongly recommend watching the archived video, which is now available on YouTube:

NOTE: This information was up-to-date at the time of the presentation but does not take into account material published since then.

If you are interested in learning more about the topic, please have a look at our research pillar about next-generation clinical trials.

Sign up for our upcoming sessions here.